Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 82Neoplasms 13Skin Neoplasms 5Brain Neoplasms 5Neoplasm Metastasis 4Carcinoma, Non-Small-Cell Lung 4Uveal Melanoma 3Thyroid Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Hematologic Neoplasms 2Glioma 2Fever 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Lymphoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 2vandetanib 1trametinib 1tislelizumab 1spartalizumab 1ribociclib 1naporafenib 1motesanib diphosphate 1milademetan 1fludarabine phosphate 1Specimen Handling 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Interleukin-13 1IFL protocol 1Gemcitabine 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × trametinib × Dermatologic × Clear all
NCT02974725 2025-04-13

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma

Novartis

Phase 1 Terminated
241 enrolled
DermatologicThoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡